Order Article Reprints

Berthold F, Ernst A, Ackermann S, Bartenhagen C, Christiansen H, Hero B, Rosswog C, von Schweinitz D, Klingebiel T, Schmid I, et al. Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by MYCN Amplification. Cancers. 2021; 13(17):4360. https://doi.org/10.3390/cancers13174360

Berthold, Frank, Angela Ernst, Sandra Ackermann, Christoph Bartenhagen, Holger Christiansen, Barbara Hero, Carolina Rosswog, Dietrich von Schweinitz, Thomas Klingebiel, Irene Schmid, and et al. 2021. "Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by MYCN Amplification" Cancers 13, no. 17: 4360. https://doi.org/10.3390/cancers13174360

Berthold, F., Ernst, A., Ackermann, S., Bartenhagen, C., Christiansen, H., Hero, B., Rosswog, C., von Schweinitz, D., Klingebiel, T., Schmid, I., Simon, T., & Fischer, M. (2021). Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by MYCN Amplification. Cancers, 13(17), 4360. https://doi.org/10.3390/cancers13174360